Covered by insurance in all 50 states, incl. Medicare Advantage day one
Siggy
Back to Blog

Low-Dose Trazodone for Sleep: What 25 to 100 mg Really Does

Clinically reviewed by Daniel Montville, MD

Reviewed October 21, 2026 · Last updated October 9, 2026

Key Takeaways

  • Trazodone is FDA-approved for depression, with a starting dose of 150 mg a day. Using lower doses for sleep is off-label, and a 2017 systematic review found that off-label insomnia use has surpassed its use as an antidepressant.
  • At low doses, trazodone mainly blocks serotonin 5-HT2A, histamine H1, and alpha-1 adrenergic receptors, which causes sleepiness. Higher doses add the serotonin reuptake blockade behind its antidepressant effect.
  • The evidence is mixed and low in certainty. Trials consistently show better perceived sleep quality and fewer awakenings, but meta-analyses disagree on whether trazodone changes measured sleep time, and daytime drowsiness is more common.
  • The American Academy of Sleep Medicine suggests against trazodone for chronic insomnia, and the American College of Physicians recommends CBT for insomnia as the first treatment for all adults.
  • Bedtime risks include dizziness on standing, next-day impairment, and rare heart rhythm problems. In older nursing home residents, fall-related injuries were about as common with low-dose trazodone as with benzodiazepines.

If you’ve been handed a prescription for 50 mg of trazodone and told it’s just to help you sleep, you may have wondered how an antidepressant ended up on your nightstand. You’re far from alone. A 2017 review of 45 studies found that off-label use of trazodone for insomnia has surpassed its use as an antidepressant.

Sleep depends partly on your brain turning down its wake signals at night. Trazodone works differently depending on the dose. At low doses it blocks receptors that help keep you alert, serotonin 5-HT2A, histamine H1, and alpha-1 adrenergic, and that produces sleepiness. Higher doses add serotonin reuptake blockade, which makes it an antidepressant, according to a CNS Spectrums review. That split is what lets prescribers aim it with some precision.

For chronic insomnia, the first-line treatment isn’t a pill. The American College of Physicians’ insomnia practice guideline recommends cognitive behavioral therapy for insomnia, or CBT-I, as the initial treatment for all adults with chronic insomnia, a strong recommendation based on moderate-quality evidence. The results are real, and the evidence is well established.

But many people start trazodone without anyone explaining what the research on it actually shows, and at Siggy we’d rather you understand the trade-offs before the first night.

This guide covers why small doses make you sleepy, what the trials found, why sleep guidelines are cautious, the risks that matter at bedtime, and how prescribers use it. Whether trazodone helps you depends less on its reputation and more on your own sleep biology.

What This Page Covers

Why Does a Low Dose of Trazodone Make You Sleepy?

Trazodone’s effects change with the dose. The CNS Spectrums review describes its hypnotic action at low doses as coming from blockade of 5-HT2A, H1, and alpha-1 receptors. At higher doses, trazodone also blocks the serotonin transporter, and that’s when it starts working as an antidepressant.

That’s why the sleep dose and the depression dose are so different. The 2017 systematic review describes low doses for insomnia as roughly 25 to 100 mg. Trazodone’s FDA label is for major depressive disorder only, with a starting dose of 150 mg a day that can rise to 400 mg a day for outpatients.

In other words, a 50 mg bedtime dose isn’t a small antidepressant dose. It’s a different use of the same molecule. Our guide to trazodone dosage compares the two ranges in more detail.

What Does the Research Show About Trazodone for Sleep?

The evidence is real but narrower than trazodone’s popularity suggests. A 2018 meta-analysis of seven placebo-controlled trials with 429 patients found that people taking trazodone rated their sleep quality as better and woke up fewer times. It found no significant improvement in sleep efficiency, time to fall asleep, total sleep time, or time awake after falling asleep, and no difference in dropouts due to side effects.

A 2022 sleep-study meta-analysis reached a more positive result. Across 11 trials with 466 participants that measured sleep overnight with polysomnography, trazodone added about 40 minutes of total sleep, shortened the time to fall asleep by about 19 minutes, and reduced awakenings. The certainty of evidence was low or very low for most of those results, some trials combined trazodone with other treatments, and daytime drowsiness was about 2.5 times as common as in control groups.

A Cochrane review of antidepressants for insomnia landed in between. It found that there may be a small improvement in sleep quality with short-term use of low-dose trazodone or doxepin, based on relatively few small studies with short follow-up. It found no evidence for long-term antidepressant use for insomnia.

The 2017 review was more favorable and concluded that the data support the efficacy and general safety of low-dose trazodone. Put together, the research suggests trazodone may help some people feel they slept better and wake less often, but the size of the benefit is uncertain and most studies were small and short.

Why Don’t Sleep Guidelines Recommend It First?

The American Academy of Sleep Medicine’s insomnia drug guideline suggests that clinicians not use trazodone to treat trouble falling asleep or staying asleep in adults with chronic insomnia. It’s a weak recommendation, which reflects limited evidence rather than proof that trazodone never helps.

The ACP guideline points first to CBT-I, a structured program that changes the habits and thoughts that keep insomnia going. It recommends adding medication only after CBT-I alone hasn’t worked, through a shared decision that weighs short-term benefits, harms, and costs.

Insomnia is also often tangled up with anxiety and depression. If that’s part of your picture, our guides to anxiety and insomnia and depression and sleep explain how they feed each other.

What Are the Risks of Low-Dose Trazodone at Bedtime?

Low doses don’t remove trazodone’s warnings. The FDA label lists several that matter most at night, which is why a prescriber needs your full health history and medication list.

Risk What the Label Says Why It Matters at Night
Low blood pressure Dizziness on standing, fainting Getting up to use the bathroom
Heart rhythm QT prolongation, torsades at 100 mg or less Matters with heart disease or other QT drugs
Next-day impairment Can slow thinking and motor skills Driving the next morning
Alcohol and sedatives Can enhance their effects Stronger sedation
Priapism Erection over 4 hours needs emergency care Rare but urgent

Falls are a real concern for older adults. A matched-cohort study of 7,791 pairs of nursing home residents aged 66 and older found fall-related injuries within 90 days in 5.7% of new low-dose trazodone users and 6.0% of new benzodiazepine users. The authors concluded low-dose trazodone was no safer than benzodiazepines for fall injuries.

The label also warns about serotonin syndrome when trazodone is combined with other serotonergic drugs, including SSRIs, and it carries a boxed warning about suicidal thoughts in young people taking antidepressants. Our guides to trazodone side effects and trazodone and alcohol go deeper.

How Do Prescribers Use Low-Dose Trazodone?

When a prescriber and patient decide trazodone makes sense, timing and follow-up matter. According to the FDA label, peak blood levels arrive about 1 hour after a dose on an empty stomach, or about 2 hours after a dose with food.

Starting low and checking in is the safer pattern, especially for older adults or anyone on other sedating or serotonergic medications. A good check-in asks how you slept, whether you feel foggy the next morning, and whether you feel dizzy when you stand up.

If you’ve been taking it regularly, don’t stop abruptly. The label recommends reducing the dose gradually when possible, because discontinuation symptoms can include insomnia, anxiety, and dizziness. Our guide to trazodone withdrawal explains what tapering can look like.

If you’re having thoughts of suicide or feel unsafe, call or text 988. In an emergency, call 911. This article is for education only and isn’t a substitute for personal medical advice. It reflects sources available as of October 2026.

Talk Through What’s Keeping You Up

Low-dose trazodone can help some people feel they slept better, but it works best as one part of a plan that looks at why sleep went off track in the first place. Our broader guide to trazodone for sleep covers safety questions people ask most. Start your anonymous intake with Siggy to describe how you’re sleeping, what’s on your mind at night, and what you’ve already tried, in your own words and at your own pace. It’s free and asks for no name or email. If anxiety or depression is part of what’s keeping you up, a licensed prescriber reviews your full clinical picture, including every medication you take, before anything is prescribed. You also get a downloadable summary you can share with any clinician.

Mental healthcare should stay with you between appointments.

Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.

Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.

Start Anonymous Intake

Frequently Asked Questions

Why is trazodone prescribed for sleep if it's an antidepressant?

Trazodone is prescribed for sleep because low doses cause sleepiness by blocking serotonin 5-HT2A, histamine H1, and alpha-1 adrenergic receptors. Its antidepressant effect requires higher doses that also block serotonin reuptake. It isn't FDA-approved for insomnia, so using it for sleep is off-label, but it's very common.

Is 50 mg of trazodone a low dose?

Yes, 50 mg is within the low-dose range of about 25 to 100 mg that's typically used for sleep. For comparison, the FDA label for depression starts at 150 mg a day and allows up to 400 mg a day for outpatients. Your prescriber chooses a sleep dose based on your age, other medications, and how you respond.

Does low-dose trazodone actually work for insomnia?

The evidence is modest and mixed. A 2018 meta-analysis of seven placebo-controlled trials found better perceived sleep quality and fewer awakenings but no significant change in time to fall asleep or total sleep time, while a 2022 meta-analysis of overnight sleep studies found more total sleep and faster sleep onset, with low-certainty evidence and more daytime drowsiness. A Cochrane review found there may be a small improvement in sleep quality with short-term use.

How long does trazodone take to work for sleep?

According to the FDA label, trazodone reaches peak blood levels about 1 hour after a dose taken on an empty stomach, or about 2 hours after a dose taken with food. Your prescriber can help you time it, and you shouldn't drive or do anything that requires alertness until you know how it affects you.

Is low-dose trazodone safe for older adults?

Low-dose trazodone needs extra caution in older adults. In a study of 7,791 matched pairs of nursing home residents aged 66 and older, fall-related injuries within 90 days were about as common with new low-dose trazodone use (5.7%) as with new benzodiazepine use (6.0%). The FDA label also warns about dizziness on standing and fainting.

Is trazodone addictive?

Trazodone isn't a controlled substance, and its FDA label notes no sign of drug-seeking behavior in clinical studies, although abuse potential hasn't been studied systematically. The label still recommends tapering gradually rather than stopping suddenly, because discontinuation symptoms can occur.

Sources

  1. Jaffer KY, Chang T, Vanle B, et al. Trazodone for insomnia: a systematic review. Innovations in Clinical Neuroscience. 2017;14(7-8):24-34. PMC5842888
  2. Stahl SM. Mechanism of action of trazodone: a multifunctional drug. CNS Spectrums. 2009;14(10):536-546. doi:10.1017/S1092852900024020
  3. Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine. 2016;165(2):125-133. doi:10.7326/M15-2175
  4. U.S. Food and Drug Administration. Desyrel (trazodone hydrochloride) tablets prescribing information. 2025. accessdata.fda.gov
  5. Yi XY, Ni SF, Ghadami MR, et al. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Medicine. 2018;45:25-32. doi:10.1016/j.sleep.2018.01.010
  6. Zheng Y, Lv T, Wu J, et al. Trazodone changed the polysomnographic sleep architecture in insomnia disorder: a systematic review and meta-analysis. Scientific Reports. 2022;12. doi:10.1038/s41598-022-18776-7
  7. Everitt H, Baldwin DS, Stuart B, et al. Antidepressants for insomnia in adults. Cochrane Database of Systematic Reviews. 2018;(5):CD010753. doi:10.1002/14651858.CD010753.pub2
  8. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2017;13(2):307-349. doi:10.5664/jcsm.6470
  9. Bronskill SE, Campitelli MA, Iaboni A, et al. Low-dose trazodone, benzodiazepines, and fall-related injuries in nursing homes: a matched-cohort study. Journal of the American Geriatrics Society. 2018;66(10):1963-1971. doi:10.1111/jgs.15519